SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artŪculo

CARRILLO RAMIREZ, L. et al. Tratamiento antitrombótico en pacientes con fibrilación auricular: estudio descriptivo en Atención Primaria. Medifam [online]. 2003, vol.13, n.4, pp.34-40. ISSN 1131-5768.

    1.  Lip G, Beevers D. ABC of Atrial Fibrillation: History, epidemiology, and importance of atrial fibrillation. BMJ 1995; 311: 1361. † [ Links ]

    2.††Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med 1995; 155: 469-73. † [ Links ]

    3.††Stern S, Altkorn D, Levinson W. Anticoagulation for chronic atrial fibrillation. JAMA 2000; 283: 2901-3. [ Links ]

    4.††Labrador MS, Merino R, Jiménez C, García Y, Segura A, Hernández C. Prevalencia de fibrilación auricular en mayores de 65 años de una zona de salud. Aten Primaria 2001; 10: 648-51. † [ Links ]

    5.††Ezekowitz MD, Levine JA. Preventing stroke in patients with atrial fibrillation. JAMA 1999; 281: 1830-5. [ Links ]

    6.††Martínez Brotons F, Comité de  Redacción de los Protocolos. Protocolos de prevención y tratamiento de la enfermedad tromboembólica (II). Prevención del embolismo de origen cardiaco. Med Clin 1994; 103: 267-70. † [ Links ]

    7.††Codinach Huix P. Fibrilación auricular de causa no valvular: indicaciones de terapia antitrombótica. Med Clin 1996; 106: 586-9. † [ Links ]

    8.††Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: †††† incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000; 35: 183-7. † [ Links ]

    9.††Rodríguez Cumplido D, Casajuana Brunet J, Botinas Martí M. Anticoagulación y fibrilación auricular no reumática. Aten Primaria 1998; 21: 553-5. [ Links ]

    10.††SPAF Investigators. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. Stroke Prevention in Atrial Fibrillation III Study. JAMA 1998; 279: 1273-7. [ Links ]

    11.††Rodríguez Suárez ML, Martínez Trabanco JI, Rodríguez Llorián AC, Cortina Llosa A. Fibrilación auricular en la práctica médica. Aten Primaria 1996; 18: 458-565. [ Links ]

    12.††Córdoba R, Hernández AC. Fibrilación auricular en el anciano. FMC-Formación Médica Continuada en Atención Primaria 1999; 6: 240-8. [ Links ]

    13.††Singer DE, Go AS. Antithrombotic therapy in atrial fibrillation. Clin Geriatr Med 2001; 17: 131-47. [ Links ]

    14.††Matteoli S, Trappolini M, Chillotti FM. Atrial fibrillation and thromboembolic events prevention. State of the art. Minerva Cardioangiol 2001; 49: 1-13. [ Links ]

    15.††Hart Rg, Halperin JL. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. Ann Intern Med 1999; 131: 688-95. [ Links ]

    16.††Pearce LA, Hart RG, Halperin J. Assessment of three schemes for stratifying risk in patients with nonvalvular atrial fibrillation. Am J Med 2000; 109: 45-51. [ Links ]

    17.††Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in atrial fibrillation: a meta-analysis. Ann Intern Med 1999: 131: 492-501. [ Links ]

    18.††The Atrial Fibrillation Investigators. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. Arch Intern Med 1997; 157: 1237-40. [ Links ]

    19.††Segal JB, McNamara RL, Miller MR, Powe NR, Goodman SN, Robinson KA, et al. Anticoagulants or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter (Cochrane Review). The Cochrane Library, Issue 1, 2001. [ Links ]

    20.††Gullow AL, Koefoed BG, Petersen P, Pedersen TS, Andersen ED, Godtfredsen J,  et al. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulant Study. Arch Intern Med 1998; 158: 1513-21. [ Links ]

    21.††Green CJ, Hadorn DC, Bassett K, Kazajian A. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analisis. Can J Cardiol 1997; 13: 811-5. [ Links ]

    22.††Taylor FC, Cohen H, Ebrahim S. Systematyc review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ 2001; 322: 321-6. [ Links ]

    23.††Koustaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of transient isquemic attacks (Cochrane Review). The Cochrane Library, Issue 1, 2001. [ Links ]

    24.††Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent  stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 1999: 131: 492-501. [ Links ]

    25.††Yamaguchi T, for Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Optimal Intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation. Stroke 2000; 31: 817-25. [ Links ]

    26.††Hart RG, Pearce LA, Miller VT, Anderson DC, Rothrock JF, Albers GW,  et al. Cardioembolic vs. noncardioembolic strokes in atrial fibrillation: frequency and effect of antithrombotic agents in the stroke prevention in atrial fibrillation studies. Cerebrovasc Dis 2000; 10: 39-43. [ Links ]

    27.††Brotons C, Moral I, Antón JJ, Cobos M, Cucurull E, Gallego C, et al. Tratamiento preventivo de la fibrilación auricular no reumática: de la eficacia de los ensayos clínicos a la efectividad en la práctica clínica. Aten Primaria 1997; 20: 367-71. [ Links ]

    28.††Galindo G, Peiró R, Plana A, Navarro MA,  Berdié J, Morató J. Profilaxis de la enfermedad tromboembólica en enfermos con cardiopatía. Aten Primaria 2000; 26: 293-7. [ Links ]

    29.††Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med 1999; 131: 927-34. [ Links ]

    30.††Aloy-Duch A, Cuenca-Luque R, Rollán-Serrano E, Casanova-Sandoval J. Utilización de trombolíticos en pacientes con fibrilación auricular crónica en un área sanitaria comarcal. Med Clin 1999; 112: 454-6. [ Links ]

    31.††Bertomeu V, et al. Estudio CARDIOTENS 99. Empleo de fármacos antitrombóticos en pacientes hipertensos con fibrilación auricular crónica. Estudio CARDIOTENS 99. Med Clin 2002; 118: 327-31. [ Links ]

    32.††Sánchez JF, García L, Chiquero M, Lozano G, Pérez S, Alonso T, et al. Tratamiento antitrombótico en la fibrilación auricular no reumática. ¿Seguimos las recomendaciones de los ensayos clínicos? An Med Interna 1999: 569-73. [ Links ]

    33.††Callejas JL, Ortego N, Díaz-Chamorro A, Troncoso E. Utilización de anticoagulación en pacientes con fibrilación auricular crónica no valvular. Med Clin 1999; 113: 679. [ Links ]

    34.††Hakey GJ. Nonvalvular atrial fibrillation and stroke prevention. National Blood Pressure Advisory Committee for the National Heart Fundation. Med J Aust 2001; 174: 234-9. [ Links ]

    35.††Koefoed BG, Gullow AL, Petersen P. Prevention of thromboembolic events in atrial fibrillation. Thromb Haemost 1997; 78: 377-81. [ Links ]

    36.††Sarmiento M, Carrillo L, Fernández Y, Cabrera N. La experiencia de nuestro centro de salud en el tratamiento anticoagulante. Aten Primaria 2001; 28: 138-9. [ Links ]

    37.††Gullow AL, Koefoed BG, Petersen P. Bleeding complications to long-term oral anticoagulant therapy. J Thromb Thrombolysis 1994; 1: 17-25. [ Links ]

    38.††Gullow AL, Koefoed BG, Petersen P. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation. Arch Intern Med 1999; 159: 1322-8. [ Links ]

    39.††Palomeras E, Roquer J, Pou A. Anticoagulación oral en la prevención secundaria de la enfermedad cerebrovascular. Seguimiento a largo plazo de 169 pacientes. Rev Neurol 1998; 27: 772-6. [ Links ]

    40.††Alonso Roca R, Alvarez Solanes, Alcaraz Betancourt A. Anticoagulación en la fibrilación auricular: implicaciones en atención primaria. Aten Primaria 1998; 21: 500-1. [ Links ]